Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obesity Treatment Using Phentermine-Topiramate ER in Adolescents and Young Adults Surviving Leukemia and Lymphoma
NCT07790913Phase 2Not yet recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 2026
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine, topiramate in obesity, sponsored by St. Jude Children's Research Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
phenterminetopiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07790913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790913.